Global Bioabsorbable Stents Market worth USD 395.5 million in 2016 and expected to reach USD 3.32 billion by 2022, at a CAGR of 42.6% from 2016 to 2022.

The global bioabsorbable stents market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the bioabsorbable stents market.

KEY BENEFITS OF THE REPORT:
In-depth analysis of the market segments that will showcase the greatest growth potential
Information about the technological advancements influencing the growth of the global market
Extensive analysis of the key players dominating the competitive landscape of this market
KEY PREMIUM INDUSTRY INSIGHTS:
As per WHO reports, cardiovascular diseases are the main cause of death than any other disorder on the global scale. It also indicates that by 2030, more than 23 million individuals will die every year from various types of cardiovascular diseases and disorders.
The increasing prevalence of cardiovascular disorders, the rising population of the obese patients, and an increasing number of cardiac surgeries are the key drivers for the bioabsorbable stents market during the forecast period.
The high risk of complications associated with the bioabsorbable stents and the limited public awareness towards the advantages of the bioabsorbable stents are the major restraining factors for the growth of this market.
MARKET SEGMENTATION:
This report analyzes the bioabsorbable stents market by the following segments:

Bioabsorbable Stents Market, by Materials
Metallic Stents
Polymeric Stents
Bioabsorbable Stents Market, by Applications
Peripheral Artery Disease
Coronary Artery Disease
Bioabsorbable Stents Market, by Absorption Rates
Slow Absorption
Fast Absorption
KEY MARKET PLAYERS:
Key players in the bioabsorbable stents market include:

Abbott Laboratories
Medtronic
Terumo Corporation
Boston Scientific Corporation
REVA Medical, Inc
BIOTRONIK, Inc.
KYOTO MEDICAL PLANNING Co., Ltd.
Elixir Medical Corporation